Radiology Solutions
AI-powered structured reporting templates for faster radiology workflows
Company profile
Company profile
Medicai is a cloud-based medical imaging infrastructure provider that delivers scalable, secure access to diagnostic imaging data across healthcare organizations. Founded to modernize legacy imaging systems, the company offers a comprehensive suite of products including cloud PACS, DICOM Gateway for automatic image retrieval, medical imaging uploader, and embeddable DICOM viewers for web and mobile applications. The platform serves healthcare providers, radiology practices, telemedicine providers, and digital health companies seeking to integrate medical imaging capabilities into their workflows. Medicai's infrastructure supports multiple specialties including orthopedics, neurology, oncology, radiology, cardiology, ophthalmology, and OB-GYN. The company's technology eliminates the need for VPNs or complex networking, enabling rapid deployment across multiple locations and imaging partners. With HIPAA and GDPR compliance, the platform provides granular access controls, automated workflows, and AI-supported diagnostics. Medicai processes over 1 million studies annually and stores 1.7 million studies, serving customers who require fast, interoperable imaging solutions that integrate seamlessly with existing EHR and EMR systems. The company offers both ready-made applications and a comprehensive Imaging API for custom integrations, positioning itself as an Imaging Infrastructure as a Service (IIaaS) provider.
Company description Medicai official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Agfa Healthcare PACS, Carestream Health, Change Healthcare Radiology Solutions, EHR systems, EMR systems, FlexView DICOM Viewer, Fujifilm Healthcare Corp, Fujifilm Synapse, GE Healthcare modalities, IBM Watson Health, Intelerad Medical Systems, MedDream DICOM Viewer, OsiriX DICOM Viewer, Philips Healthcare modalities, Sectra PACS, Siemens Healthineers modalities.
Company milestones
New pricing model launched, expanded product portfolio including AI co-pilot for radiology, structured reporting capabilities
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered structured reporting templates for faster radiology workflows
Multi-location cloud PACS with integrated DICOM viewer and built-in AI capabilities
Automated medical imaging retrieval from PACS and modalities in minutes
Zero-footprint embeddable DICOM viewer for web and mobile applications
Web portal for doctors to access and analyze medical imaging with AI-Copilot
RESTful API for seamless medical imaging integration into healthcare systems
Secure patient upload portal for medical imaging studies and clinical documents
Mobile DICOM viewer app for on-the-go medical image analysis and collaboration
Secure patient portal for receiving medical images and reports online
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
IET systems biology · Jan 1, 2026
Association of the triglyceride-glucose index with all-cause and cause-specific mortality in patients with comorbid hypertension and diabetes: A population-based cohort study.American heart journal plus : cardiology research and practice · Dec 1, 2025
From synthesis to properties: expanding the horizons of machine learning in nanomaterials research.Materials horizons · Jun 16, 2025
Clinical and Multiorgan Proteomics Characteristics of the Diverse Fatal Phase in Super Elderly Patients With SARS-CoV-2 Infection: A Descriptive Study.Journal of medical virology · Feb 1, 2025
Predictive value of preoperative platelet count and D-dimer levels for spinal cord injury following acute type a aortic dissection.Journal of cardiothoracic surgery · Mar 13, 2024
A review on ethnobotany, phytochemistry, and pharmacology of the genus Duhaldea DC.Frontiers in pharmacology · Jan 1, 2024
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Platform throughput and scale
Total imaging data managed
User engagement and platform usage
API integration activity
DICOM Gateway deployment speed
Workflow efficiency improvement
Advancing radiology education through seamless case sharing, image annotation, and collaborative discussions
Enhanced learning and collaboration within radiology community
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Medicai's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.